How a young Peninsula company snagged a onetime Roche exec to battle sepsis

The Burlingame company is taking a different approach to uncovering the source of life-threatening infections — one that could decrease the use of antibiotics and appealed to the former chief medical officer of Roche Molecular Diagnostics.